EGFR and lung adenocarcinoma: We retrospectively evaluated the outcomes of Caucasian women with lung adenocarcinoma, undergoing first-line platinum-based CT and subsequent salvage anti-EGFR TKI therapy, in relation to EGFR and K-Ras mutational status.